Project Grant HT94252310235
Award Date
9/15/23
Completion Date
9/14/27
Dollars Obligated
$3.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $1,100,633 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports cancer research and translational science initiatives at the University of North Carolina at Chapel Hill (UNC-CH). Specifically, the award will fund innovative biomedical research projects focused on transforming healthcare for military service members and the broader public. Research areas may include disease prevention, diagnosis, treatment, and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,541,280.00 to the University of North Carolina at Chapel Hill to support the "The Breast Cancer Cellular Atlas" research project. This multi-year project, running from March 2025 through February 2029, will conduct innovative biomedical research to advance understanding and treatment of breast cancer. The funding will enable UNC-Chapel...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,511,536.00 to the University of North Carolina at Chapel Hill (UNC-CH) to conduct a Testis Cancer Survivorship Study. The award period runs from July 1, 2024 to June 30, 2028. UNC-CH, through its Office of Sponsored Research, will execute this biomedical research initiative to transform healthcare for military service members and...
This $544,250 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of North Carolina at Chapel Hill to develop combination therapies to overcome chemoresistance in Ewing sarcoma. The research project, which has a performance period from August 15, 2024 to August 14, 2027, aims to advance innovative therapeutic approaches to improve outcomes for this rare and aggressive form of cancer. As a...
The University of North Carolina at Chapel Hill will use a $1,265,834 project grant from the Department of the Army Medical Command to support research titled "GD2 CART FOR LUNG CANCER" under the Military Medical Research and Development program (CFDA 12.420). The three-year award beginning September 30, 2022 will fund the development of chimeric antigen receptor T-cell (CART) therapies targeting the GD2 antigen for treatment of lung cancer. The Military Medical Research and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,244,000.00 to the University of North Carolina at Chapel Hill to conduct research targeting the E3 ligase SPOP in treating renal cell carcinoma. The award period runs from July 1, 2024 to June 30, 2028. The University of North Carolina at Chapel Hill, a major public research university, has extensive experience managing large-scale federally-funded...
This federal Project Grant award of $509,979.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports biomedical research initiatives at the University of North Carolina at Chapel Hill (UNC-CH) to develop potentiated chip variants as therapeutics to alleviate tau pathology and neurodegeneration. The award, with a performance period from July 1, 2025 to June 30, 2028, will fund innovative research projects aimed at transforming...
The University of North Carolina at Chapel Hill received a $1,555,000 Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund a 3-year research project to measure the autonomic nervous system responses of warfighters following exertion and resting stressors. This research aims to advance understanding of how the autonomic nervous system is impacted by physical and psychological stressors...
This federal Project Grant award in the amount of $4,503,963 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports a research project titled "Spatial Reprogramming of Tumor Immune Microenvironments by Preoperative Radiotherapy and Immune Checkpoint Inhibition in HER2 Negative Breast Cancer." The project is being led by the University of North Carolina at Chapel Hill (UNC-CH) through its Office of Sponsored...
This Project Grant award from the Department of the Army Medical Command provides $583,652 to the University of North Carolina at Chapel Hill for the development of CART cells for lung cancer. The award is being made under the Military Medical Research and Development program (CFDA 12.420) to support basic, applied, and advanced biomedical research that transforms healthcare for service members and the public. Through this three-year award ending September 2025, the University of North...